{
     "PMID": "27567806",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20180126",
     "LR": "20180131",
     "IS": "1875-8908 (Electronic) 1387-2877 (Linking)",
     "VI": "54",
     "IP": "3",
     "DP": "2016 Oct 4",
     "TI": "Reduction of Blood Amyloid-beta Oligomers in Alzheimer's Disease Transgenic Mice by c-Abl Kinase Inhibition.",
     "PG": "1193-1205",
     "AB": "One of the pathological hallmarks of Alzheimer's disease (AD) is the presence of amyloid plaques, which are deposits of misfolded and aggregated amyloid-beta peptide (Abeta). The role of the c-Abl tyrosine kinase in Abeta-mediated neurodegeneration has been previously reported. Here, we investigated the therapeutic potential of inhibiting c-Abl using imatinib. We developed a novel method, based on a technique used to detect prions (PMCA), to measure minute amounts of misfolded-Abeta in the blood of AD transgenic mice. We found that imatinib reduces Abeta-oligomers in plasma, which correlates with a reduction of AD brain features such as plaques and oligomers accumulation, neuroinflammation, and cognitive deficits. Cells exposed to imatinib and c-Abl KO mice display decreased levels of beta-CTF fragments, suggesting that an altered processing of the amyloid-beta protein precursor is the most probable mechanism behind imatinib effects. Our findings support the role of c-Abl in Abeta accumulation and AD, and propose AD-PMCA as a new tool to evaluate AD progression and screening for drug candidates.",
     "FAU": [
          "Estrada, Lisbell D",
          "Chamorro, David",
          "Yanez, Maria Jose",
          "Gonzalez, Marcelo",
          "Leal, Nancy",
          "von Bernhardi, Rommy",
          "Dulcey, Andres E",
          "Marugan, Juan",
          "Ferrer, Marc",
          "Soto, Claudio",
          "Zanlungo, Silvana",
          "Inestrosa, Nibaldo C",
          "Alvarez, Alejandra R"
     ],
     "AU": [
          "Estrada LD",
          "Chamorro D",
          "Yanez MJ",
          "Gonzalez M",
          "Leal N",
          "von Bernhardi R",
          "Dulcey AE",
          "Marugan J",
          "Ferrer M",
          "Soto C",
          "Zanlungo S",
          "Inestrosa NC",
          "Alvarez AR"
     ],
     "AD": "Cell Signaling Laboratory, Cell and Molecular Biology Department, Biological Sciences Faculty, Pontificia Universidad Catolica de Chile, Chile. Centro de Envejecimiento y Regeneracion (CARE), Departamento de Biologia Celular, Facultad de Ciencias Biologicas, Pontificia Universidad Catolica de Chile, Chile. Laboratorio Bionanotecnologia, Facultad de Salud, Universidad Bernardo O Higgins, Chile. Cell Signaling Laboratory, Cell and Molecular Biology Department, Biological Sciences Faculty, Pontificia Universidad Catolica de Chile, Chile. Cell Signaling Laboratory, Cell and Molecular Biology Department, Biological Sciences Faculty, Pontificia Universidad Catolica de Chile, Chile. Cell Signaling Laboratory, Cell and Molecular Biology Department, Biological Sciences Faculty, Pontificia Universidad Catolica de Chile, Chile. Cell Signaling Laboratory, Cell and Molecular Biology Department, Biological Sciences Faculty, Pontificia Universidad Catolica de Chile, Chile. Department of Neurology, School of Medicine, Pontificia Universidad Catolica de Chile, Chile. National Center for Advancing Translational Science (NACTS), NIH, Bethesda, MD, USA. National Center for Advancing Translational Science (NACTS), NIH, Bethesda, MD, USA. National Center for Advancing Translational Science (NACTS), NIH, Bethesda, MD, USA. Mitchell Center for Alzheimer's Disease and Related Brain Disorders, University of Texas Medical School at Houston, Houston, TX, USA. Gastroentorology Department, School of Medicine, Pontificia Universidad Catolica de Chile, Chile. Centro de Envejecimiento y Regeneracion (CARE), Departamento de Biologia Celular, Facultad de Ciencias Biologicas, Pontificia Universidad Catolica de Chile, Chile. Centre for Healthy Brain Ageing, School of Psychiatry, Faculty of Medicine, University of New South Wales, Australia. Centro de Excelencia en Biomedicina de Magallanes (CEBIMA), Universidad de Magallanes, Chile. Cell Signaling Laboratory, Cell and Molecular Biology Department, Biological Sciences Faculty, Pontificia Universidad Catolica de Chile, Chile. Centro de Envejecimiento y Regeneracion (CARE), Departamento de Biologia Celular, Facultad de Ciencias Biologicas, Pontificia Universidad Catolica de Chile, Chile.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "Netherlands",
     "TA": "J Alzheimers Dis",
     "JT": "Journal of Alzheimer's disease : JAD",
     "JID": "9814863",
     "RN": [
          "0 (Amyloid beta-Peptides)",
          "0 (Protein Kinase Inhibitors)",
          "EC 2.7.10.2 (Proto-Oncogene Proteins c-abl)"
     ],
     "SB": "IM",
     "MH": [
          "Alzheimer Disease/*blood/*enzymology/pathology",
          "Amyloid beta-Peptides/*blood",
          "Animals",
          "Cell Line",
          "Hippocampus/drug effects/metabolism/pathology",
          "Mice",
          "Mice, Knockout",
          "Mice, Transgenic",
          "Protein Kinase Inhibitors/*pharmacology",
          "Proto-Oncogene Proteins c-abl/*antagonists & inhibitors/*blood"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "*Alzheimer's disease",
          "*PMCA",
          "*amyloid-beta peptide",
          "*amyloid-beta protein precursor",
          "*c-Abl tyrosine kinase",
          "*imatinib",
          "*oligomers"
     ],
     "EDAT": "2016/08/29 06:00",
     "MHDA": "2018/01/27 06:00",
     "CRDT": [
          "2016/08/29 06:00"
     ],
     "PHST": [
          "2016/08/29 06:00 [pubmed]",
          "2018/01/27 06:00 [medline]",
          "2016/08/29 06:00 [entrez]"
     ],
     "AID": [
          "JAD151087 [pii]",
          "10.3233/JAD-151087 [doi]"
     ],
     "PST": "ppublish",
     "SO": "J Alzheimers Dis. 2016 Oct 4;54(3):1193-1205. doi: 10.3233/JAD-151087.",
     "term": "hippocampus"
}